Press releases
2013
26 February, 2013
Go-ahead for PledPharma to proceed with PLIANT study patient recruitment
21 February, 2013
PledPharma AB (publ) Full Year Report 2012
20 February, 2013
PledPharma's patent application approved and issued in USA
12 February, 2013
First patient included into PledPharma’s PLIANT study
30 January, 2013
PLIANT study starts in the U.S.
9 January, 2013
Nortal Investments Acquires Additional Shares in PledPharma
2012
19 December, 2012
PledPharma Broadens Patient Base for the PLIANT Study
26 October, 2012
PledPharma AB (publ) Interim report January-September 2012
24 August, 2012
PledPharma AB (publ) Interim report January – June 2012
1 August, 2012
PledPharma PledOx® clinical trial application approved
6 July, 2012
PledPharma’s PledOx® safety studies positive
27 April, 2012
Interim report January-March 2012
3 April, 2012
PledPharma receives 500,000 SEK in VINNOVA financing
17 February, 2012
PledPharma AB (publ) Full year report January – December 2011
20 January, 2012
PledPharma’s patient study showing reduced number of serious adverse events in chemotherapy treatment published in scientific journal
2011
15 December, 2011
PledPharma’s clinical myocardial infarction study restarted after approval from the Medical Products Agency
5 December, 2011
PledPharma’s PledOx® protects against white blood cell drop caused by the anticancer drug oxaliplatin
27 October, 2011
Interim report January - September 2011
20 September, 2011
PledPharma strengthens its organization
Calendar and upcoming reports
August 22, 2024
Interim Report Q2 2024 (7:00am CEST)
September 19, 2024
Pareto Annual Healthcare Conference
